Polymorphisms in microRNA target sites of forkhead box O genes are associated with Hepatocellular Carcinoma

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Tan, Chao ^a   Liu, Shun ^a   Tan, Shengkui ^b   Zeng, Xiaoyun ^a   Yu, Hongping ^b   Li, Anhua ^a   Bei, Chunhua ^b   Qiu, Xiaoqiang ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 137; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL 4; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; MIRN137 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BINDING AFFINITY; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; EPISTASIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HEK293 CELL LINE; LIVER TUMOR; MIDDLE AGED;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FORKHEAD TRANSCRIPTION FACTORS; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HEK293 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84928905842     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119210     Document Type: Article

References (41)

1. Farazi PA, De Pinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nature Reviews Cancer. 2006;6:674-687. PMID: 16929323
2. Calnan DR, Brunet A. The FoxO code. Oncogene. 2008;27:2276-2288. doi: 10.1038/onc.2008.21 PMID: 18391970
3. Alikhani M, Alikhani Z, Graves DT. FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis. Journal of Biological Chemistry. 2005;280:12096-12102. PMID: 15632117
4. Ward EC, Hoekstra AV, Blok LJ, Hanifi-Moghaddam P, Lurain JR, Singh DK, et al. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma. Endocrinology. 2008;149:1942-1950. PMID: 18096667
5. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004;117:421-426. PMID: 15137936
6. Maiese K, Chong ZZ, Shang YC, Hou J. A "FOXO" in sight: targeting Foxo proteins from conception to cancer. Medicinal research reviews. 2009;29:395-418. doi: 10.1002/med.20139 PMID: 18985696
7. Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP. Identification of a tumour suppressor network opposing nuclear Akt function. Nature. 2006;441:523-527. PMID: 16680151
8. Paik J-H, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z, et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 2007;128:309-323. PMID: 17254969
9. Arden KC. FoxOs in tumor suppression and stem cell maintenance. Cell. 2007;128:235-237. PMID: 17254960
10. Fu Z, Tindall D. FOXOs, cancer and regulation of apoptosis. Oncogene. 2008;27:2312-2319. doi: 10. 1038/onc.2008.24 PMID: 18391973
11. Greer E, Brunet A. FOXO transcription factors in ageing and cancer. Acta physiologica. 2008;192:19-28. doi: 10.1111/j.1748-1716.2007.01780.x PMID: 18171426
12. Fei M, Lu M, Wang Y, Zhao Y, He S, Gao S, et al. Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization. Medical Oncology. 2009;26:178-185. doi: 10.1007/s12032-008-9105-8 PMID: 18937079
13. Lee S-Y, Lee GR, Woo D-H, Park NH, Cha HJ, Moon Y, et al. Depletion of Aurora A leads to upregulation of FoxO1 to induce cell cycle arrest in hepatocellular carcinoma cells. Cell Cycle. 2013;12:67. PMID: 23255113
14. Lu M, Ma J, Xue W, Cheng C, Wang Y, Zhao Y, et al. The expression and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma. Pathology & Oncology Research. 2009;15:679-687.
15. Horie Y, Suzuki A, Kataoka E, Sasaki T, Hamada K, Sasaki J, et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. Journal of Clinical Investigation. 2004;113:1774-1783. PMID: 15199412
16. Sethupathy P, Collins FS. MicroRNA target site polymorphisms and human disease. Trends in genetics. 2008;24:489-497. doi: 10.1016/j.tig.2008.07.004 PMID: 18778868
17. Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin Y, Wang E, et al. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic acids research. 2007;35:4535-4541. PMID: 17584784
18. Pezzoli K, Tukey R, Sarabia H, Zaslavsky I, Miranda ML, Suk WA, et al. The NIEHS Environmental Health Sciences Data Resource Portal: placing advanced technologies in service to vulnerable communities. Environmental health perspectives. 2007;115:564-571. PMID: 17450225
19. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, Qi L, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic acids research. 2006;34:D617-D621. PMID: 16381944
20. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic acids research. 2008;36:D149-D153. PMID: 18158296
21. Chun HB, Xiao QQ, Xiao YZ, Yan Y, Jin MH, Xue JF. Association of interleukin-10 gene poly morphism with hepatocellular carcinoma. Chinese Journal of Public Health. 2011;27:309-311.
22. Zeng XY, Yu HP, Qiu XQ, Ji L, Li LM. Correlation of polymorphism of DNA repair gene XRCC3 with susceptibility to hepatocellular carcinoma in regions of high HCC incidence rate in Guangxi. Chinese Journal of Cancer Prevention and Treatment. 2009;16:1629-1633.
23. Zhang Y, Gan B, Liu D, Paik JH. FoxO family members in cancer. Cancer biology & therapy. 2011;12:253-259.
24. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer cell. 2003;4:257-262. PMID: 14585353
25. Nakae J, Kitamura T, Kitamura Y, Biggs WH III, Arden KC, Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Developmental cell. 2003;4:119-129. PMID: 12530968
26. Tomasetti M, Nocchi L, Staffolani S, Manzella N, Amati M, Goodwin J, et al. MicroRNA-126 Suppresses Mesothelioma Malignancy by Targeting IRS1 and Interfering with Mitochondrial Function. Antioxidants & redox signaling. 2014;21:2109-2125.
27. Niedan S, Kauer M, Aryee D, Kofler R, Schwentner R, Meier A, et al. Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma. Oncogene. 2013;33:3927-3938. doi: 10.1038/onc.2013.361 PMID: 23995784
28. Park J, San Ko Y, Yoon J, Kim MA, Park J-W, Kim WH, et al. The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway. Gastric Cancer. 2013;17:1-8. doi: 10.1007/s10120-013-0252-z PMID: 23563986
29. Huang CY, Chan CY, Chou IT, Lien CH, Hung HC, Lee MF, et al. Quercetin induces growth arrest through activation of FOXO1 transcription factor in EGFR-overexpressing oral cancer cells. The Journal of nutritional biochemistry. 2013;24:1596-1603. doi: 10.1016/j.jnutbio.2013.01.010 PMID: 23618529
30. Fendler A, Jung M, Stephan C, Erbersdobler A, Jung K, Yousef GM, et al. The Antiapoptotic Function of miR-96 in Prostate Cancer by Inhibition of FOXO1. PloS one. 2013;8:e80807. doi: 10.1371/journal. pone.0080807 PMID: 24260486
31. Guttilla IK, White BA. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem. 2009;284:23204-23216. doi: 10.1074/jbc. M109.031427 PMID: 19574223
32. Furukawa-Hibi Y, Kobayashi Y, Chen C, Motoyama N. FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Antioxidants & redox signaling. 2005;7:752-760.
33. Jones SM. Connecting signaling and cell cycle progression in growth factor-stimulated cells. Oncogene. 2000;19:5558-67. PMID: 11114735
34. Hou T, Ou J, Zhao X, Huang X, Huang Y, Zhang Y. MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27 (Kip1). Br J Cancer. 2014;110:1260-1268. doi: 10. 1038/bjc.2013.829 PMID: 24423924
35. Wu L, Li H, Jia CY, Cheng W, Yu M, Peng M, et al. MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett. 2012;586:1038-1043. doi: 10.1016/j.febslet.2012.02.050 PMID: 22569260
36. Liang L, Li X, Zhang X, Lv Z, He G, Zhao W, et al. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. Gastroenterology. 2013;144:624-635. doi: 10.1053/j.gastro.2012.11.033 PMID: 23201162
37. Langevin SM, Stone RA, Bunker CH, Lyons-Weiler MA, La Framboise WA, Kelly L, et al. MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck. Cancer. 2011;117:1454-1462. doi: 10.1002/cncr.25689 PMID: 21425146
38. Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, Coffey DG, et al. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res. 2008;68:1362-1368. doi: 10.1158/0008-5472. CAN-07-2912 PMID: 18316599
39. Yang J, Zhou F, Xu T, Deng H, Ge Y, Zhang C, et al. Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2008;638:205-209.
40. Chen CJ, Chen DS. Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology. Hepatology. 2002;36:1046-1049. PMID: 12395312
41. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ. Ap53genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology. 1999;29:697-702. PMID: 10051470